rct
    2022
    High Quality

    Citicoline in acute ischemic stroke: A randomized controlled trial

    et al

    Published in PLoS One

    Key Findings

    No significant difference between citicoline and placebo on primary or secondary outcomes, including penumbral tissue salvage.

    Conclusions

    Citicoline did not reduce infarct progression or improve outcomes in acute ischaemic stroke.

    Limitations

    Modest sample; single-region recruitment.

    Supplements Studied

    We did not find any significant difference between the Citicoline or placebo arms with respect to either our primary or secondary outcomes.

    Outcomes Measured

    Cerebral Infarction Volume

    We did not find any significant difference between the Citicoline or placebo arms with respect to either our primary or secondary outcomes.

    Related Health Concerns

    Ischemic Stroke

    Study Details

    Year:2022
    Quality Score:7/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.